# Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects

> **NCT07277933** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Chengdu Kanghong Pharmaceutical Group Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** KHN702
- **DRUG:** KHN702 placebo

## Key facts

- **NCT ID:** NCT07277933
- **Lead sponsor:** Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07277933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07277933, "Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07277933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*